Company Story
Innovators
Metabolica Health is a preclinical biotech company developing a first-in-class, oral therapy for diabetes, obesity, and metabolic liver disease. Our approach is rooted in the microbiome: we’re advancing a small molecule, 4-cresol, that restores the body’s ability to produce insulin and rebalance metabolism.
Unlike current treatments that manage symptoms, we target the biological root of disease — with regenerative effects on the insulin-producing pancreatic β-cells and broader benefits across systemic metabolism.
Backed by peer-reviewed publications, a granted U.S. patent, and global academic partnerships, Metabolica is building a scalable therapeutic platform with broad clinical potential and clear translational focus.
Our leadership team combines deep scientific expertise with operational and business experience to translate discovery into real-world impact.
